{"id":"dextrose-5-in-water-d5w","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hyponatremia (with prolonged use)"},{"rate":null,"effect":"Phlebitis at infusion site"},{"rate":null,"effect":"Fluid overload"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"D5W is a hypotonic crystalloid solution that delivers dextrose (glucose) and water intravenously. The dextrose is metabolized for energy and the water distributes across intracellular and extracellular compartments, providing both modest caloric support and free water for rehydration. It is commonly used for maintenance fluid therapy and to prevent dehydration in hospitalized patients.","oneSentence":"Dextrose 5% in water provides a source of glucose and free water for intravenous hydration and caloric supplementation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:44:43.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Intravenous hydration and maintenance fluid therapy"},{"name":"Caloric supplementation in hospitalized patients"},{"name":"Prevention and treatment of dehydration"}]},"trialDetails":[{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":"Post-Treatment Lyme Disease","enrollment":44},{"nctId":"NCT07386327","phase":"NA","title":"Impact of Bupivacaine Dilution With Dextrose or Saline on Infraclavicular Block Outcomes","status":"RECRUITING","sponsor":"Burçin Alaçam, MD","startDate":"2026-03-09","conditions":"Infraclavicular Brachial Plexus Block, Dextrose, Bupivacaine","enrollment":90},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT07382596","phase":"PHASE4","title":"Cervical Plexus Hydrodissection With D5W Versus NS for Treatment-Resistant PTSD","status":"NOT_YET_RECRUITING","sponsor":"Dr. Dean Reeves Clinic","startDate":"2026-03-01","conditions":"PTSD","enrollment":50},{"nctId":"NCT06785402","phase":"PHASE1, PHASE2","title":"Ceftriaxone for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-02-15","conditions":"Post-Treatment Lyme Disease Syndrome","enrollment":20},{"nctId":"NCT01319565","phase":"PHASE2","title":"Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-03-24","conditions":"Metastatic Melanoma, Skin Cancer","enrollment":102},{"nctId":"NCT03608033","phase":"PHASE3","title":"Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy","status":"TERMINATED","sponsor":"Omeros Corporation","startDate":"2018-04-05","conditions":"IgA Nephropathy","enrollment":360},{"nctId":"NCT04082533","phase":"PHASE4","title":"Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2019-07-24","conditions":"Pain, Arthrofibrosis, Osteoarthritis, Knee","enrollment":132},{"nctId":"NCT05286775","phase":"NA","title":"Knee Osteoarthritis Disabling Pain Program for the Brazilian Unified Health System","status":"COMPLETED","sponsor":"Marta Imamura","startDate":"2022-03-15","conditions":"Osteoarthritis, Knee","enrollment":71},{"nctId":"NCT04459052","phase":"PHASE2","title":"FDOPA PET and Nutritional Support in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2020-04-30","conditions":"Parkinson Disease, Idiopathic Parkinson Disease","enrollment":50},{"nctId":"NCT00878254","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"University of Miami","startDate":"2009-03-25","conditions":"Mantle-Cell Lymphoma","enrollment":25},{"nctId":"NCT07013812","phase":"PHASE4","title":"Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section","status":"COMPLETED","sponsor":"Combined Military Hospital Multan","startDate":"2023-11-01","conditions":"Cesarean Section, Blood Loss During Surgery","enrollment":68},{"nctId":"NCT03440450","phase":"PHASE1","title":"A Phase 1 Dose-escalation Study of FF-10832 for Treatment of Solid Tumors Including Biliary Tract Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fujifilm Pharmaceuticals U.S.A., Inc.","startDate":"2018-03-22","conditions":"Advanced Solid Tumors, Biliary Tract Cancer","enrollment":90},{"nctId":"NCT05113966","phase":"PHASE2","title":"Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer","status":"TERMINATED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-12-08","conditions":"Triple Negative Breast Cancer","enrollment":30},{"nctId":"NCT04935359","phase":"PHASE3","title":"Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-09-30","conditions":"Metastatic Pancreatic Ductal Adenocarcinoma","enrollment":511},{"nctId":"NCT04323436","phase":"PHASE2","title":"Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-08-19","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":31},{"nctId":"NCT01969409","phase":"PHASE2","title":"Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2014-01","conditions":"Ambulatory IPF","enrollment":58},{"nctId":"NCT04799249","phase":"PHASE3","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)","status":"COMPLETED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-05-14","conditions":"TNBC - Triple-Negative Breast Cancer, Breast Cancer","enrollment":194},{"nctId":"NCT02061800","phase":"PHASE1, PHASE2","title":"CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diane George","startDate":"2013-06-03","conditions":"Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS)","enrollment":14},{"nctId":"NCT02925416","phase":"PHASE4","title":"Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2017-01-24","conditions":"Skin Diseases, Bacterial","enrollment":22},{"nctId":"NCT04404387","phase":"PHASE3","title":"Lessening Organ Dysfunction With VITamin C in Septic ARDS","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-07-22","conditions":"Septic, Acute Respiratory Distress Syndrome","enrollment":800},{"nctId":"NCT02471690","phase":"PHASE1","title":"Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2015-07","conditions":"Healthy","enrollment":56},{"nctId":"NCT03829683","phase":"PHASE2","title":"Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2019-04-16","conditions":"Alcoholic Hepatitis, Sepsis","enrollment":20},{"nctId":"NCT04294472","phase":"PHASE2","title":"A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Vera Therapeutics, Inc.","startDate":"2020-08-05","conditions":"BK Virus Infection","enrollment":30},{"nctId":"NCT04401150","phase":"PHASE3","title":"Lessening Organ Dysfunction With VITamin C - COVID-19","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2020-08-14","conditions":"Vitamin C, COVID-19, Hospitalized Patients","enrollment":392},{"nctId":"NCT04863248","phase":"PHASE2","title":"Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4)","status":"TERMINATED","sponsor":"G1 Therapeutics, Inc.","startDate":"2021-04-30","conditions":"Metastatic Non-Small Cell Lung Cancer, NSCLC, Lung Cancer","enrollment":10},{"nctId":"NCT03617289","phase":"NA","title":"Efficacy of Magnesium Sulfate on Reducing Renal Colic in the Emergency Department","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2016-01","conditions":"Renal Colic","enrollment":37},{"nctId":"NCT01376778","phase":"PHASE3","title":"A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2012-04","conditions":"Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection","enrollment":399},{"nctId":"NCT00616941","phase":"PHASE1","title":"Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2008-03","conditions":"Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":28},{"nctId":"NCT03680274","phase":"PHASE3","title":"Lessening Organ Dysfunction With VITamin C","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2018-11-08","conditions":"Sepsis, Vitamin C, Intensive Care Unit","enrollment":872},{"nctId":"NCT02111850","phase":"PHASE1, PHASE2","title":"T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-02-07","conditions":"Cervical Cancer, Renal Cancer, Urothelial Cancer","enrollment":21},{"nctId":"NCT03254394","phase":"PHASE1, PHASE2","title":"Lidocaine for Oxaliplatin-induced Neuropathy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-09-15","conditions":"Neuropathy, Painful, Chemotherapy-induced Peripheral Neuropathy, Colorectal Cancer","enrollment":26},{"nctId":"NCT03130790","phase":"PHASE2, PHASE3","title":"Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)","status":"COMPLETED","sponsor":"ASLAN Pharmaceuticals","startDate":"2017-08-31","conditions":"Gastric Cancer","enrollment":52},{"nctId":"NCT03180307","phase":"PHASE3","title":"OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer","status":"COMPLETED","sponsor":"On Target Laboratories, LLC","startDate":"2018-01-26","conditions":"Ovarian Cancer","enrollment":140},{"nctId":"NCT02802228","phase":"PHASE2","title":"Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2017-03-06","conditions":"Portal Hypertension, Liver Cirrhosis","enrollment":30},{"nctId":"NCT02173990","phase":"PHASE2","title":"Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).","status":"TERMINATED","sponsor":"Centre Oscar Lambret","startDate":"2014-07","conditions":"Metastatic Colorectal Cancer","enrollment":40},{"nctId":"NCT03089671","phase":"NA","title":"Ureteric Visualization: Vitamin B Vs 5% Dextrose in Water","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2017-12-07","conditions":"Pelvic Floor Disorders, Ureter; Kink","enrollment":238},{"nctId":"NCT01967823","phase":"PHASE2","title":"T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-10-24","conditions":"Melanoma, Meningioma, Breast Cancer","enrollment":11},{"nctId":"NCT02592798","phase":"PHASE2","title":"Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2016-03-09","conditions":"Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change Disease","enrollment":36},{"nctId":"NCT01778634","phase":"PHASE2","title":"Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2013-07","conditions":"Ureaplasma Infections","enrollment":121},{"nctId":"NCT01167569","phase":"PHASE4","title":"Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2007-10","conditions":"Reperfusion Injury","enrollment":57},{"nctId":"NCT02100748","phase":"PHASE2","title":"A Study of TRV130 for the Treatment of Pain After Bunionectomy","status":"COMPLETED","sponsor":"Trevena Inc.","startDate":"2014-04","conditions":"Acute Pain","enrollment":333},{"nctId":"NCT02335294","phase":"PHASE2","title":"A Study of TRV130 for the Treatment of Pain After Abdominoplasty","status":"COMPLETED","sponsor":"Trevena Inc.","startDate":"2014-12","conditions":"Pain","enrollment":200},{"nctId":"NCT04509440","phase":"NA","title":"Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis \"NPCAB\"","status":"COMPLETED","sponsor":"University of Alexandria","startDate":"2018-05-01","conditions":"Anserine Bursitis","enrollment":43},{"nctId":"NCT02267317","phase":"PHASE2","title":"The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects","status":"TERMINATED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2015-01","conditions":"Insulin Sensitivity","enrollment":15},{"nctId":"NCT01218867","phase":"PHASE1, PHASE2","title":"CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-11-10","conditions":"Metastatic Cancer, Metastatic Melanoma, Renal Cancer","enrollment":24},{"nctId":"NCT00670748","phase":"PHASE2","title":"Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-05-29","conditions":"Metastatic Melanoma, Metastatic Renal Cell Cancer, Metastatic Cancer","enrollment":45},{"nctId":"NCT00941655","phase":"PHASE3","title":"Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2009-07-22","conditions":"Gastric Cancer","enrollment":15},{"nctId":"NCT01583686","phase":"PHASE1, PHASE2","title":"CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-05-04","conditions":"Cervical Cancer, Pancreatic Cancer, Ovarian Cancer","enrollment":15},{"nctId":"NCT02321111","phase":"PHASE2","title":"The Role of TLR4 on Lipid-induced Insulin Resistance","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2015-01","conditions":"Insulin Sensitivity","enrollment":10},{"nctId":"NCT04110418","phase":"PHASE2","title":"Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-02-19","conditions":"Neonatal Sepsis, Refractory Shock","enrollment":36},{"nctId":"NCT01454596","phase":"PHASE1, PHASE2","title":"CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-05-16","conditions":"Malignant Glioma, Glioblastoma, Brain Cancer","enrollment":18},{"nctId":"NCT00066469","phase":"PHASE2","title":"Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2004-04","conditions":"Lymphoproliferative Disorder","enrollment":55},{"nctId":"NCT01681095","phase":"PHASE2","title":"Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent","status":"COMPLETED","sponsor":"Marc Sakwa, MD","startDate":"2012-08","conditions":"Coronary Artery Disease, Myocardial Ischemia, Coronary Disease","enrollment":110},{"nctId":"NCT03587441","phase":"PHASE4","title":"Intrathecal Neostigmine for Prevention of PDPH","status":"COMPLETED","sponsor":"Fayoum University Hospital","startDate":"2018-08-04","conditions":"Post-Dural Puncture Headache","enrollment":240},{"nctId":"NCT01384877","phase":"PHASE2, PHASE3","title":"Subcutaneous Lidocaine For Cancer-Related Pain","status":"COMPLETED","sponsor":"British Columbia Cancer Agency","startDate":"2011-12","conditions":"Cancer-related Pain","enrollment":33},{"nctId":"NCT02153905","phase":"PHASE1, PHASE2","title":"T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-07-03","conditions":"Breast Cancer, Cervical Cancer, Renal Cancer","enrollment":3},{"nctId":"NCT02103998","phase":"PHASE3","title":"Study of Thyroid Hormones in Prematures","status":"WITHDRAWN","sponsor":"New York Medical College","startDate":"2020-07-01","conditions":"Transient Hypothyroxinemia of Prematurity (THOP)","enrollment":""},{"nctId":"NCT00801931","phase":"PHASE1, PHASE2","title":"Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders","status":"TERMINATED","sponsor":"Columbia University","startDate":"2007-09-06","conditions":"Leukemia, Lymphoma, Neuroblastoma","enrollment":1},{"nctId":"NCT01814046","phase":"PHASE2","title":"Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-03-01","conditions":"Metastatic Ocular Melanoma, Metastatic Uveal Melanoma","enrollment":24},{"nctId":"NCT00543309","phase":"PHASE2","title":"Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery","status":"TERMINATED","sponsor":"John M Costello","startDate":"2007-10","conditions":"Heart Defects, Congenital","enrollment":106},{"nctId":"NCT01547364","phase":"PHASE2","title":"Caudal Epidural Injection of Dextrose For Low Back Pain","status":"COMPLETED","sponsor":"Smigel, Liza, M.D.","startDate":"2012-02","conditions":"Back Pain Lower Back Chronic","enrollment":35},{"nctId":"NCT01585428","phase":"PHASE2","title":"Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-04-13","conditions":"Cervical Cancer, Oropharyngeal Cancer, Vaginal Cancer","enrollment":29},{"nctId":"NCT02686385","phase":"NA","title":"Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury","status":"TERMINATED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-03-01","conditions":"Drug Induced Liver Injury","enrollment":4},{"nctId":"NCT00349778","phase":"PHASE2","title":"High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma","status":"COMPLETED","sponsor":"Stanford University","startDate":"2006-08","conditions":"Multiple Myeloma","enrollment":102},{"nctId":"NCT01638104","phase":"PHASE1","title":"ANX-042 Healthy Volunteer Dose Escalation Study","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2012-08","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT02111863","phase":"PHASE2","title":"Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-02-21","conditions":"Melanoma, Skin Cancer","enrollment":6},{"nctId":"NCT00609245","phase":"PHASE4","title":"Effect of Valproic Acid Concentration on Photic Response","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-12","conditions":"Photosensitive Epilepsy","enrollment":13},{"nctId":"NCT03084809","phase":"PHASE4","title":"Chemotherapy Combined With CIK Treating Colon Cancer","status":"COMPLETED","sponsor":"China Meitan General Hospital","startDate":"2012-05-06","conditions":"Colorectal Cancer, Cytokine-induced Killer Cells, Postoperative Complications","enrollment":46},{"nctId":"NCT01436500","phase":"PHASE2","title":"Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2011-10","conditions":"Hepatorenal Syndrome","enrollment":55},{"nctId":"NCT02596477","phase":"PHASE2","title":"Evaluation of Vepoloxamer in Chronic Heart Failure","status":"TERMINATED","sponsor":"Mast Therapeutics, Inc.","startDate":"2015-10","conditions":"Chronic Heart Failure","enrollment":10},{"nctId":"NCT00248625","phase":"PHASE3","title":"N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2000-01","conditions":"Acute Liver Failure, Hepatic Encephalopathy","enrollment":184},{"nctId":"NCT01468818","phase":"PHASE2","title":"Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-09","conditions":"Metastatic Melanoma, Skin Cancer","enrollment":18},{"nctId":"NCT02062359","phase":"PHASE2","title":"T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2014-02","conditions":"Metastatic Cancer, Metastatic Melanoma","enrollment":2},{"nctId":"NCT02034591","phase":"PHASE1","title":"Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2011-10","conditions":"Healthy Subjects","enrollment":37},{"nctId":"NCT01356303","phase":"PHASE2","title":"Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer","status":"SUSPENDED","sponsor":"National Guard Health Affairs","startDate":"2009-03","conditions":"Non-small Cell Lung Cancer Metastatic","enrollment":50},{"nctId":"NCT01236573","phase":"PHASE1, PHASE2","title":"Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes","status":"TERMINATED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2010-10","conditions":"Skin Cancer, Metastatic Melanoma","enrollment":34},{"nctId":"NCT00450801","phase":"PHASE2","title":"R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"University of Miami","startDate":"2004-04","conditions":"Lymphoma","enrollment":22},{"nctId":"NCT00612222","phase":"PHASE2","title":"Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-01","conditions":"Metastatic Melanoma, Skin Cancer","enrollment":4},{"nctId":"NCT00610311","phase":"PHASE2","title":"Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-01","conditions":"Metastatic Melanoma, Skin Cancer","enrollment":3},{"nctId":"NCT00924287","phase":"PHASE1, PHASE2","title":"Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-11","conditions":"Metastatic Cancer","enrollment":1},{"nctId":"NCT02331069","phase":"NA","title":"Delto-Tricipital Compression Syndrome: Treated With Injection of Dextrose","status":"UNKNOWN","sponsor":"Universidad Abierta Interamericana","startDate":"2015-01","conditions":"Superficial Radial Nerve Lesion","enrollment":80},{"nctId":"NCT01605279","phase":"PHASE2","title":"Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns","status":"COMPLETED","sponsor":"Adelina Pellicer","startDate":"2010-09","conditions":"Hemodynamic Instability","enrollment":127},{"nctId":"NCT01407900","phase":"PHASE1","title":"Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction","status":"WITHDRAWN","sponsor":"John A. Schirger","startDate":"2014-01","conditions":"Heart Failure, Renal Insufficiency","enrollment":""},{"nctId":"NCT00436644","phase":"PHASE2","title":"Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2007-03","conditions":"Ovarian Cancer, Peritoneal Cavity Cancer","enrollment":18},{"nctId":"NCT00504257","phase":"PHASE2","title":"Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2007-03","conditions":"Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum","enrollment":45},{"nctId":"NCT00795678","phase":"","title":"Chemotherapeutic Agents in Brain/Breast","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2008-09","conditions":"Breast Cancer, Metastatic Cancer","enrollment":10},{"nctId":"NCT01825473","phase":"NA","title":"Study of Erythromycin in GER-Associated Apnea of the Newborn","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2012-09","conditions":"Gastroesophageal Reflux, Apnea, Bradycardia","enrollment":40},{"nctId":"NCT01617577","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Filgrastim in Alzheimer's Disease","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2009-06","conditions":"Alzheimer's Disease","enrollment":8},{"nctId":"NCT00612014","phase":"PHASE2","title":"Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2007-10","conditions":"Gastroparesis, Diabetes Mellitus","enrollment":78},{"nctId":"NCT00617552","phase":"PHASE2","title":"Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2007-07","conditions":"Postoperative Ileus","enrollment":267},{"nctId":"NCT00787761","phase":"PHASE2","title":"Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer","status":"COMPLETED","sponsor":"Northside Hospital, Inc.","startDate":"2007-04","conditions":"Myeloproliferative Disorders, Kidney Cancer, Leukemia","enrollment":24},{"nctId":"NCT00048932","phase":"PHASE3","title":"A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2002-12","conditions":"Rheumatoid Arthritis","enrollment":1795},{"nctId":"NCT00250029","phase":"NA","title":"Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen","status":"COMPLETED","sponsor":"New Mexico Cancer Research Alliance","startDate":"2004-04","conditions":"Colonic Diseases, Cancer","enrollment":30},{"nctId":"NCT00393029","phase":"PHASE2","title":"Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2006-10","conditions":"Anti-p53 TCR-Gene","enrollment":12},{"nctId":"NCT00740727","phase":"PHASE1","title":"EASI Access II --- Follow-up Study to the EASI Access Trial","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-02","conditions":"Disaster Medicine, Difficult Intravenous Access, Dehydration","enrollment":18},{"nctId":"NCT00639808","phase":"PHASE1","title":"Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis","status":"COMPLETED","sponsor":"Tranzyme, Inc.","startDate":"2006-08","conditions":"Gastroparesis, Diabetes Mellitus","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":187,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"marketed","status":"active","brandName":"Dextrose 5% in water (D5W)","genericName":"Dextrose 5% in water (D5W)","companyName":"Hospital for Special Surgery, New York","companyId":"hospital-for-special-surgery-new-york","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dextrose 5% in water provides a source of glucose and free water for intravenous hydration and caloric supplementation. Used for Intravenous hydration and maintenance fluid therapy, Caloric supplementation in hospitalized patients, Prevention and treatment of dehydration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}